Geisel researchers take a close look at New Hampshire’s complex opioid epidemic, and one city’s novel response.
In a briefing to the House Bipartisan Heroin Task Force, Geisel professor Lisa Marsch, PhD, Principal Investigator of the Northeast Node of the National Drug Abuse (NIDA) Clinical Trials Network, presented data from her NIDA-funded New Hampshire Hot Spot Study on heroin and synthetic drug use.
Geisel professor Lisa Marsch is leading a project with colleagues from across the U.S. to develop and test a smart watch able to detect cocaine use, in real time, by capturing heart rate data.
Lisa Marsch, PhD, a professor of psychiatry and director of the Dartmouth Center for Technology and Behavioral Health, has been appointed to the Andrew G. Wallace Professorship at the Geisel School of Medicine.
The Center for Technology and Behavioral Health has been awarded a $5 million grant from the National Institutes of Health to study the mechanisms—psychological or biological—that underpin motivation, with an eye to developing better strategies that can help all of us improve our health.
The National Institute on Drug Abuse (NIDA) has awarded a five-year $3.8 million grant to Dartmouth’s Center for Technology and Behavioral Health. The award will support the launch of the new Northeast Node in NIDA’s National Clinical Trials Network, and clinical trials conducted by the Node will be supported by additional research project grants from NIDA, part of the National Institutes of Health.
A recent trial led by Lisa Marsch, an associate professor of psychiatry at Geisel, could help extend the reach of evidence-based behavioral health treatments.
Health apps for smartphones are nothing new. Now, health-care providers are increasingly using sophisticated technology-based medical applications to help patients manage chronic illnesses.